A61P 1 - Drugs for disorders of the alimentary tract or the digestive system

Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
12/2001
12/05/2001	EP0548103B1 Use of pyridylmethylsulphinyl-1h-benzimidazole derivates in the treatment of illnesses caused by helicobacter bacteria
12/05/2001	CN1325408A Compounds with growth hormone releasing propenties
12/05/2001	CN1325403A Bile-acid substituted phenyl-alkenoylguanidines, method for the production thereof, use thereof as medicaments or diaymostic agents and medicaments that contain
12/05/2001	CN1325399A Pyrroloindoles, pyridoindoles and azepinoindoles as 5-HT2c agonists
12/05/2001	CN1325385A Gastrin and cholecystokinin receptor ligands
12/05/2001	CN1325384A Anthranilic acid amides and the use thereof as medicaments
12/05/2001	CN1325302A Use of dialkylfumarates
12/05/2001	CN1325300A Pharmaceutical formulation comprising omeprazole
12/05/2001	CN1325277A Composition comprising a viscosity modulating polymer material and its use
12/05/2001	CN1324951A High-efficiency expression and application of human recombinant interferon B
12/05/2001	CN1324661A Human hepatitis B nucleic acid vaccine
12/05/2001	CN1324654A Cold eliminating pellet
12/05/2001	CN1324648A Quick-acting gastropathy treating medicine powder and its prepn.
12/05/2001	CN1324644A Compound liver-protecting tea and its prepn.
12/05/2001	CN1324640A External-use medicine for treating cough and diarrhoea in the four seasons
12/05/2001	CN1324629A Gastropathy treating medicine and its prepn.
12/05/2001	CN1324624A Stomach and kidney disease treating medicine powder
12/05/2001	CN1075816C Methods for in vivo reduction of nitric oxide levels and compositions sueful therefor
12/05/2001	CN1075812C Prodrugs of morpholine tachykinin receptor antagonists
12/05/2001	CN1075802C Asiatic acid derivatives having modified A-ring
12/04/2001	US6326507 Therapeutic compounds and methods of use
12/04/2001	US6326492 Heterocyclic protease inhibitors
12/04/2001	US6326388 Substituted 1,3,4-oxadiazoles and a method of reducing TNF-alpha level
12/04/2001	US6326384 Dry blend pharmaceutical unit dosage form
12/04/2001	US6326383 Emesis therapy
12/04/2001	US6326359 Adenosine A2A receptor agonists as antiinflammatory agents
12/04/2001	US6326171 Hepatitis C E1 and E2 truncated polypeptides and methods of obtaining the same
12/04/2001	CA2229814C Peripherally active anti-hyperalgesic opiates
12/04/2001	CA2214386C Optically active thiazolidinone derivatives
11/2001
11/29/2001	WO2001090371A1 Mutated eukariotic translation initiation factor 2 alpha kinase 3, eif2ak3, in patients with neonatal insulin-dependent diabetes and multiple epiphyseal dysplasia (wolcott-rallison syndrome)
11/29/2001	WO2001090359A2 G-protein coupled receptors
11/29/2001	WO2001090334A2 Drug metabolizing enzymes
11/29/2001	WO2001090333A2 Recombinant bacterial phytases and uses thereof
11/29/2001	WO2001090311A1 Novel probiotics for pet food applications
11/29/2001	WO2001090251A1 Antimicrobial composition
11/29/2001	WO2001090186A1 Methods for identifying modulators of the interaction between lap (latency associated peptide) and intergrin alpha.v.beta.3 and medical use thereof
11/29/2001	WO2001090162A1 Crystal structure data of cystalysin and use thereof for the design and preparation of inhibitor molecules
11/29/2001	WO2001090156A2 Card domain containing polypeptides, encoding nucleic acids, and methods of use
11/29/2001	WO2001090155A2 Novx proteins and nucleic acids encoding same. diagnostic and therapeutic uses
11/29/2001	WO2001090129A2 Prophylactic and therapeutic treatment of infectious, autoimmune and allergic diseases with mono and disaccharide-base compounds
11/29/2001	WO2001090121A2 Methods and compositions for treating hepatitis c virus
11/29/2001	WO2001090110A1 Macrolides
11/29/2001	WO2001090106A2 Tryasolyl tropane derivatives as ccr5 modulators
11/29/2001	WO2001090104A2 -(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as modulators of protein kinases
11/29/2001	WO2001090103A2 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as protein kinase modulators
11/29/2001	WO2001090101A1 Arylmethylamine derivatives for use as tryptase inhibitors
11/29/2001	WO2001090086A1 A polymorph of 5-(4-aminosulfonyl-3-fluorophenyl)-4-cyclohexyl-2-methyloxazole
11/29/2001	WO2001090083A1 1,4-diazepan-2,5-dione derivatives and their use as nk-1 receptor antagonists
11/29/2001	WO2001090082A1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
11/29/2001	WO2001090081A1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
11/29/2001	WO2001090078A1 Pyrazole derivatives and their use as gastrin and cholecystokin in receptor ligands
11/29/2001	WO2001090076A1 Fluoroalkoxy-substituted benzamide dichloropyridinyl n-oxide pde4 inhibitor
11/29/2001	WO2001090074A2 BENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a)
11/29/2001	WO2001090070A2 Caspase inhibitors and uses thereof
11/29/2001	WO2001090069A1 Novel calcium receptor active molecules and method for preparing same
11/29/2001	WO2001090068A2 Mannich base prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use a modulators of protein kinases
11/29/2001	WO2001090063A2 Prodrug of an ice inhibitor
11/29/2001	WO2001090060A1 Disulfide derivatives useful for treating allergic diseases
11/29/2001	WO2001090052A1 Cyclic amino acid derivatives useful as pharmaceutical agents
11/29/2001	WO2001090047A1 Novel mmp-2/mmp-9 inhibitors
11/29/2001	WO2001089570A2 Combination of growth hormone secretagogues and antidepressants
11/29/2001	WO2001089569A1 Combinations of enzyme inhibitor-containing preparations and the use thereof
11/29/2001	WO2001089552A1 Modulaton of alpha-6 integrin-mediated responses
11/29/2001	WO2001089549A2 Therapeutic uses of il-1 receptor antagonist
11/29/2001	WO2001089546A2 Treatment for irritable bowel syndrome and related conditions
11/29/2001	WO2001089538A2 Apoptotic entities for use in treatment of endothelium dysfunction disorders
11/29/2001	WO2001089536A2 Apoptotic entities for use in treatment of t-cell-mediated and inflammatory disorders
11/29/2001	WO2001089534A1 Use of metal compounds to treat gastrointestinal infections
11/29/2001	WO2001089520A2 Dehydroascorbic acid formulations and uses thereof
11/29/2001	WO2001089515A1 Pharmaceutical combination of bicalutamide and tamoxifen for providing an anti-androgenic effect and an anti-oestrogenic effect
11/29/2001	WO2001089506A1 Medicaments for treating colics
11/29/2001	WO2001089485A1 Rapidly disintegrating tablet and process for the manufacture thereof
11/29/2001	WO2001089451A2 Protease inhibitors
11/29/2001	WO2001089364A2 Hcv variants
11/29/2001	WO2001089361A2 Diagnosis, prevention and treatment of crohn's disease using the ompc antigen
11/29/2001	WO2001070695A8 Pyridine derivatives as inhibitors of p38
11/29/2001	WO2001060835A8 Purine derivatives
11/29/2001	WO2001055115A8 Substituted nicotinamides and analogs as activators of caspases and inducers of apoptosis and the use thereof
11/29/2001	WO2001049305A3 Process for obtaining thylakoids from plants, pure thylakoids and use thereof
11/29/2001	WO2001042272A3 Eplerenone crystalline form exhibiting enhanced dissolution rate
11/29/2001	WO2001019776A3 Novel derivatives of dicarboxylic acid having pharmaceutical properties
11/29/2001	WO2000055159A3 Substituted aza-oxindole derivatives
11/29/2001	WO2000039114A3 Substituted oximes and hydrazones as neurokinin antagonists
11/29/2001	US20010047030 Somatostatin antagonists and agonists that act at the SST subtype 2 receptor
11/29/2001	US20010047008 Allosteric adenosine receptor modulators
11/29/2001	US20010046993 5-memberd heteroaryl substituted 1,4-dihydropyridine compounds as bradykinin antagonists
11/29/2001	US20010046959 Method of treating cancer with anti-neurotrophin agents
11/29/2001	US20010046957 Administering interferon-alpha or a pegylated derivative and a salt or prodrug of mycophenolic acid
11/29/2001	US20010046511 Water soluble film for oral administration with instant wettability
11/29/2001	US20010046496 Administering to the human having a disease associated with leukocyte infiltration of mucosal tissues a humanized immunoglobulin or antigen-binding fragment having binidng specificity for alpha 4 beta 7 integrain
11/29/2001	US20010046493 Lipase-containing composition and methods of use thereof
11/29/2001	US20010046490 Cell surface molecule-induced macrophage activation
11/29/2001	US20010046482 Enhance motility of the digestive tract and/or contractility of the lower esophageal sphincter
11/29/2001	DE10123349A1 New N-sulfonylated pipecolic acid derivatives, are matrix metalloprotease inhibitors useful e.g. for treating rheumatism, tumor progression, arteriosclerosis or inflammatory bowel disease
11/29/2001	DE10025728A1 Neue Carbamate und Harnstoffe, ihre Herstellung und Verwendung als Endothelin-Rezeptorantagonisten New carbamates and ureas, their preparation and use as endothelin receptor antagonists
11/29/2001	CA2712547A1 Methods and compositions for treating hepatitis c virus
11/29/2001	CA2429199A1 Drug metabolizing enzymes
11/29/2001	CA2410593A1 Novel mmp-2/mmp-9 inhibitors
11/29/2001	CA2410520A1 Mutated eukariotic translation initiation factor 2 alpha kinase 3, eif2ak3, in patients with neonatal insulin-dependent diabetes and multiple epiphyseal dysplasia (wolcott-rallison syndrome)
11/29/2001	CA2410096A1 Card domain containing polypeptides, encoding nucleic acids, and methods of use

1 ... 1002 1003 1004 1005 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 ... 1258